Table 1.
Groups | AST (IU/L) | ALT (IU/L) | γ-GT (IU/L) | Creatinine (mg/dL) | Urea (mg/dL) |
---|---|---|---|---|---|
FST | 143 ± 28 | 62 ± 12 | 1.2 ± 0.4 | 0.30 ± 0.03 | 44 ± 2.1 |
NeBa | 138 ± 17 | 65 ± 7.7 | 1.1 ± 0.3 | 0.31 ± 0.04 | 44 ± 6.2 |
Dex | 150 ± 28 | 80 ± 17 | 0.9 ± 0.3 | 0.27 ± 0.03 | 43 ± 5.6 |
Col | 153 ± 29 | 63 ± 12 | 1.0 ± 0.2 | 0.30 ± 0.05 | 45 ± 4.6 |
Emulgel | 146 ± 6.1 | 65 ± 8.5 | 1.1 ± 0.2 | 0.26 ± 0.04 | 44 ± 4.7 |
Car | 124 ± 14 | 60 ± 9.5 | 1.1 ± 0.2 | 0.31 ± 0.03 | 42 ± 7.6 |
Control | 147 ±25 | 65 ± 9.1 | 1.0 ± 0.2 | 0.30 ± 0.02 | 44 ± 4.9 |
One-way ANOVA followed by Tukey test, with p ≤0.05 (n =5). FST: wounded animal without treatment; NeBa: wounded animal treated with neomycin 5 mg/g + sulfate bacitracin zinc 250 IU/g; Dex: wounded animals treated with dexpanthenol 5%; Col: wounded animals treated with collagenase 1.2 IU; Emulgel: wounded animals treated with emulgel (vehicle); Car: wounded animals treated with β-caryophyllene emulsion; Control: animals without lesion and treatment – physiologic pattern.